Verweise von und zu Rosacea
Zurück zum ArtikelVerweise von anderen Artikeln
- Acne rosacea
- Acne rosacea
- Adipokine
- Alcohol skin changes
- Alumina
- Ammonium bituminosulfonate, light
- Angiosarcoma of the head and face skin
- antimicrobial peptides
- Eye diseases, skin changes
- Azelaic acid
- Bitter substances
- Flash lamps
- Camouflage
- Carvedilol
- Cathelicidins
- Cathelicidins
- CCL2
- Demodex folliculorum
- Demodex folliculitis
- Erlotinib
- Erythema
- Erythema perstans faciei
- Folliculitis gramnegative
- Facial erythema
- Glucorticosteroids topical
- Gnathophyma
- Haber`s syndrome
- Keratosis lichenoides chronica
- Conjunctivitis in rosacea
- Copper fin
- Swelling of the eyelids
- Lupus erythematodes chronicus discoides
- Maskne
- Menstrual cycle, skin changes
- Metronidazole
- Miliarial type primary cutaneous follicle center lymphoma
- Milia multiple eruptive
- Morbus Morbihan
- Neurogenic rosacea
- Orange peel phenomenon
- Rhinophyma
- Rhinophyma paraphrased
- Rosacea conglobata
- Rosacea fulminans
- Juvenile rosacea
- Rosacea papulopustulosa
- Rosacea tablepharitis
- Rosacea gramnegative
- Rosacea conjunctivitis
- Rosacea lupoid
- ROSCO
- red scrotum syndrome (rss)
- Red fin
- Russell corpuscles
- Rutoside
- Seborrhoea
- Sebum
- SIBO Syndrome
- Spironolactone
- Steroid rosacea
- Teleangiectasia
- Teleangiectasia
- Tetracyclines
- Tinea faciei
- Tyrosine kinase inhibitors
- no translation
- Gluten-Related Dermatological Disorders
Verweise zu anderen Artikeln
- Masking paste hydrophobic skin color/reddish (nrf 11.58.)
- Adapalen
- Acne (overview)
- Actinic reticuloid
- Angiogenesis
- Basal cell carcinoma (overview)
- Bateman, thomas
- Benzyl benzoate
- Botulinum toxin a
- Brimonidine
- BTNL2 gene
- Calcitonin gene related peptide receptor
- Carvedilol
- Catechine
- Cathelicidins
- Cetuximab
- Chronic actinic dermatitis (overview)
- Clarithromycin
- Cxcl1
- Cxcl2
- Cxcl6
- Cyproterone acetate
- Demodex folliculorum
- Demodex folliculitis
- Dermatomyositis (overview)
- Doxycycline
- Dupilumab
- EGF receptor inhibitors
- Erlotinib
- Erysipelas
- Erythrophobia
- Erythema perstans faciei
- Exanthema, acneiformes
- Facies leontina
- Flush
- Folliculitis gramnegative
- Gefitinib
- Glucocorticosteroids
- Gluten
- Gnathophyma
- HTR3A gene
- Imatinib
- Immunity, innate
- Interleukin-17 cytokines
- Interleukin-3
- Interleukin-8
- Interleukins
- Isotretinoin
- Ivermectin
- Kallikrein
- Kaposi, moriz
- Carcinoid syndrome
- Keratinocyte
- Lupus erythematosus systemic
- Lupus miliaris disseminatus faciei
- Lupus pernio
- Lymphocyte
- Macrolide antibiotics
- Mast cell
- Metophyme
- Metronidazole
- Minocycline
- Morbus Morbihan
- Nilotinib
- Off-label use
- Otophyma
- Oxymetazoline
- Paroxetine
- Perioral dermatitis
- Permethrin cream 2.5/5%
- Pimecrolimus
- Pituitary adenylate-cyclase-activating polypeptide
- Polycythaemia vera
- Prevalence
- Pustule
- Rhinophyma
- Rosacea conglobata
- Rosacea erythematosa
- Rosacea fulminans
- Rosacea papulopustulosa
- Rosacea glandular-hyperplastic
- Rosacea gramnegative
- Rosacea lupoid
- Rosacea ocular
- ROSCO
- Roxithromycin
- Rutoside
- Scarlet fever
- Thyroid carcinomas
- Seborrheic dermatitis of adults
- Steroid skin
- Steroid rosacea
- Substance p
- Tacrolimus
- Teleangiectasia
- Tetracyclines
- Tinea faciei
- TNF-alpha
- TRPA1
- TRP-channels
- TRPV1
- Tyrosine kinase inhibitors
- Vegf
- Vip